Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 11/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 7/20 | 1.00 |
| ▸ | ADORA2A | P29274 | 9/20 | 0.66 |
| ▸ | PDE4A | P27815 | 7/20 | 0.66 |
| ▸ | PDE4B | Q07343 | 7/20 | 0.66 |
| ▸ | PDE4C | Q08493 | 7/20 | 0.66 |
| ▸ | PDE4D | Q08499 | 7/20 | 0.66 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | RGS12 | O14924 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.38 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.38 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5134361 | 0.98 | ADORA2B (0.97) | ADORA2BADORA3ADORA2APDE4APDE4B | |
| SCHEMBL8536544 | 0.82 | ADORA2B (0.70) | ADORA2BADORA3ADORA2APDE4APDE4B | |
| SCHEMBL2143506 | 0.82 | ADORA2B (0.70) | ADORA2BADORA3ADORA2APDE4APDE4B | |
| SCHEMBL10818065 | 0.82 | ADORA2B (0.70) | ADORA2BADORA3ADORA2APDE4APDE4B | |
| SCHEMBL7491460 | 0.82 | ADORA2B (0.70) | ADORA2BADORA3ADORA2APDE4APDE4B | |
| SCHEMBL2842239 | 0.82 | ADORA2B (0.70) | ADORA2BADORA3ADORA2APDE4APDE4B | |
| SCHEMBL941660 | 0.82 | ADORA2B (0.70) | ADORA2BADORA3ADORA2APDE4APDE4B | |
| SCHEMBL380135 | 0.80 | ADORA2A (1.00) | ADORA2BADORA3ADORA2APDE4APDE4B | |
| SCHEMBL27586849 | 0.80 | ADORA2A (0.71) | ADORA2BADORA3ADORA2APDE4APDE4B | |
| SCHEMBL5515444 | 0.80 | ADORA2A (0.71) | ADORA2BADORA3ADORA2APDE4APDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0755254-B1 | PREVENTION AND TREATMENT OF ISCHEMIA-REPERFUSION AND ENDOTOXIN-RELATED INJURY USING ADENOSINE AND PURINO RECEPTOR ANTAGONISTS | UNIV PENNSYLVANIA (US) | 2005-05-18 | — | — | EP | claimed |
| EP-0755254-A4 | PREVENTION AND TREATMENT OF ISCHEMIA-REPERFUSION AND ENDOTOXIN-RELATED INJURY USING ADENOSINE AND PURINO RECEPTOR ANTAGONISTS | UNIV PENNSYLVANIA (US) | 2002-01-16 | — | — | EP | claimed |
| EP-0755254-A1 | PREVENTION AND TREATMENT OF ISCHEMIA-REPERFUSION AND ENDOTOXIN-RELATED INJURY USING ADENOSINE AND PURINO RECEPTOR ANTAGONISTS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1997-01-29 | — | — | EP | claimed |
| US-5504090-A | Compositions and methods for the prevention and treatment of ischemia-reperfusion organ injury | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1996-04-02 | — | — | US | claimed |
| WO-1995026728-A1 | PREVENTION AND TREATMENT OF ISCHEMIA-REPERFUSION AND ENDOTOXIN-RELATED INJURY USING ADENOSINE AND PURINO RECEPTOR ANTAGONISTS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1995-10-12 | — | — | WO | claimed |
| EP-0502043-A1 | UTILIZATION OF XANTHINES, OPTIONALLY INCORPORATED IN LIPOSOMES IN ORDER TO HELP THE PIGMENTATION OF SKIN OR HAIR. | LVMH RECH (FR) | 1992-09-09 | — | — | EP | claimed |
| WO-1991007945-A1 | UTILIZATION OF XANTHINES, OPTIONALLY INCORPORATED IN LIPOSOMES IN ORDER TO HELP THE PIGMENTATION OF SKIN OR HAIR | LVMH RECHERCHE (FR) | 1991-06-13 | — | — | WO | claimed |
| JP-54088296-A | — | — | None | — | — | JP | disclosed |
| JP-54088297-A | — | — | None | — | — | JP | disclosed |
| JP-6192260-A | — | — | None | — | — | JP | disclosed |
| JP-54115392-A | — | — | None | — | — | JP | disclosed |
| EP-4662319-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | Integrate Bioscience LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024168301-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | FUNCTION ONCOLOGY, INC. (US) | 2024-08-15 | — | — | WO | disclosed |
| WO-1991007945-A1 | UTILIZATION OF XANTHINES, OPTIONALLY INCORPORATED IN LIPOSOMES IN ORDER TO HELP THE PIGMENTATION OF SKIN OR HAIR | LVMH RECHERCHE (FR) | 1991-06-13 | — | — | WO | disclosed |
| US-4772607-A | ALZHEIMER*S DISEASE, CNS STIMULANT, ANTIFIBRILLATORY, BRONCHODILATOR | WARNER-LAMBERT COMPANY (US) | 1988-09-20 | — | — | US | disclosed |
| CN-85106465-A | A kind of preparation process of pharmaceutical preparation | — | 1986-10-29 | — | — | CN | disclosed |
| US-4450163-A | ANTIBODY INHIBITORS; N-ALKYLATION OF XANTHINES USING PHASE TRANSFER AGENTS | SOCIETE D'ASSISTANCE TECHNIQUE POUR PRODUITS NESTLE S.A. (CH) | 1984-05-22 | — | — | US | disclosed |
| JP-S54115392-A | PREPARATION OF OXOHEXYLXANTHINE | NIKKEN KAGAKU KK | 1979-09-07 | — | — | JP | disclosed |
| JP-S5488297-A | PRODUCTION OF OXOALKYLXANTHINE | NIKKEN KAGAKU KK | 1979-07-13 | — | — | JP | disclosed |
| JP-S5488296-A | PRODUCTION OF OXOALKYLXANTHINE DERIVATIVE | NIKKEN KAGAKU KK | 1979-07-13 | — | — | JP | disclosed |